comparemela.com
Home
Live Updates
Submits Supplemental New Drug Application - Breaking News
Pages:
Latest Breaking News On - Submits supplemental new drug application - Page 1 : comparemela.com
Johnson & Johnson : 2023 Third-Quarter Press Release & Supplemental Schedules -October 17, 2023 at 06:45 am EDT
Media contact: Investor contact: .
Joaquin duato
Tesia williams
Jessica moore
European medicines agency seeking approval
Exchange commission
Drug administration seeking
European academy of dermatology
Finalizes separation of kenvue inc
Johnson announces final results of exchange
Janssen highlights latest research
Consumer health company
Trueref technology for mapping
Nipocalimab clinical development program to address unmet
Consumer health
Interventional solutions
Janssen to highlight latest research
Johnson & Johnson Reports Q3 2023 Results
2023 Third-Quarter reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4% and adjusted operational growth of 4.9% . Operational growth excluding COVID-19 Vaccine of.
Joaquin duato
Janssen to highlight latest research
Finalizes separation of kenvue inc
Johnson announces final results of exchange
Consumer health
European commission approves
Interventional solutions
Company consumer health
European society of retina specialists
Exchange commission
European medicines agency seeking approval of erdafitinib
European academy of dermatology
Janssen highlights latest research
Consumer health company
Drug administration seeking full approval
European medicines agency
Johnson & Johnson : Janssen Submits Supplemental New Drug Application to the U S Food and Drug Administration Seeking Full Approval of BALVERSA® (erdafitinib) for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations -Today at 09:18 am
News Release Media Contacts: Suzanne Frost Phone: +1 416-317-0304 Ania DiAntonio .
Peter lebowitz
Ania diantonio
Drug administration
Astex pharmaceuticals
Administration seeking full approval
American society of clinical oncologyannual meeting
Janssen pharmaceutical companies of johnson
Janssen research development
News release
Submits supplemental new drug application
Seeking full approval
Locally advanced
Metastatic urothelial carcinoma
Confirmatory data
Which showed
Patients treated
Rare Diseases News | Live Feed & Top Stories
Read the latest Rare Diseases headlines - updated 24/7/365. We link to the best sources from around the world. Get the latest on Rare Disease.
United kingdom
City of
North carolina
United states
Hong kong
Medtech summitsharecast
Caelum biosciences
Giantseeking alpha
Officerali hariri
Sheikh mohamed
Lise lund kjems
Erik atkisson
Abu dhabi
Harsha rajasimha
Aliza fink
Astrazeneca alexion
vimarsana © 2020. All Rights Reserved.